γ-Catenin is an independent prognostic marker in early stage colorectal cancer

International Journal of Colorectal Disease

Volumn 25, Issue 11, 2010, Pages 1301-1309

  Nagel, Jutta Maria ^a,c   Kriegl, Lydia ^b   Horst, David ^b   Engel, Jutta ^a   Gautam, Shiva ^c   Mantzoros, Christos S ^c   Kirchner, Thomas ^b   Göke, Burkhard ^a   Kolligs, Frank Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Pathology   (Germany)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

catenin; catenin; Colorectal cancer; Prognostic marker

Indexed keywords

BETA CATENIN; PLAKOGLOBIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL MEMBRANE; CELL NUCLEUS; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; CYTOPLASM; DEATH; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE RISK; TISSUE MICROARRAY; TUMOR PROMOTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COHORT STUDIES; COLORECTAL NEOPLASMS; CYTOPLASM; DEMOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 78149408059     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1046-y     Document Type: Article

References (30)

1. FT Kolligs G Bommer B Goke 2002 Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis Digestion 66 131 144 1:CAS:528:DC%2BD38XpsV2htLs%3D 10.1159/000066755 12481159
2. K Caca FT Kolligs X Ji, et al. 1999 Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer Cell Growth Differ 10 369 376 1:CAS:528:DyaK1MXktVCnu74%3D 10392898
3. S Kodama S Ikeda T Asahara M Kishida A Kikuchi 1999 Axin directly interacts with plakoglobin and regulates its stability J Biol Chem 274 27682 27688 1:CAS:528:DyaK1MXmtlOksb0%3D 10.1074/jbc.274.39.27682 10488109
4. FT Kolligs B Kolligs KM Hajra, et al. 2000 gamma-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin Genes Dev 14 1319 1331 1:CAS:528:DC%2BD3cXjvFOgsbo%3D 10837025
5. O Maeda N Usami M Kondo, et al. 2004 Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line Oncogene 23 964 972 1:CAS:528:DC%2BD2cXntlelsA%3D%3D 10.1038/sj.onc. 1207254 14661054
6. H Aberle A Bauer J Stappert A Kispert R Kemler 1997 Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J 16 3797 3804 1:CAS:528:DyaK2sXkslShsbk%3D 10.1093/emboj/16.13.3797 9233789
7. M Shtutman J Zhurinsky M Oren E Levina A Ben-Ze'ev 2002 PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription Cancer Res 62 5947 5954 1:CAS:528:DC%2BD38XotFyktLY%3D 12384561
8. J Zhurinsky M Shtutman A Ben-Ze'ev 2000 Plakoglobin and beta-catenin: protein interactions, regulation and biological roles J Cell Sci 113 Pt 18 3127 3139 1:CAS:528:DC%2BD3cXnsVyltL4%3D 10954412
9. J Zhurinsky M Shtutman A Ben-Ze'ev 2000 Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin Mol Cell Biol 20 4238 4252 1:CAS:528:DC%2BD3cXjvFWrs70%3D 10.1128/MCB.20.12.4238-4252.2000 10825188
10. S Miravet J Piedra F Miro E Itarte HA de Garcia M Dunach 2002 The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin J Biol Chem 277 1884 1891 1:CAS:528:DC%2BD38XosFegsg%3D%3D 10.1074/jbc.M110248200 11711551
11. BO Williams GD Barish MW Klymkowsky HE Varmus 2000 A comparative evaluation of beta-catenin and plakoglobin signaling activity Oncogene 19 5720 5728 1:CAS:528:DC%2BD3cXoslylsLg%3D 10.1038/sj.onc.1203921 11126358
12. I Simcha M Shtutman D Salomon, et al. 1998 Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin J Cell Biol 141 1433 1448 1:CAS:528:DyaK1cXjvFKktrw%3D 10.1083/jcb.141.6.1433 9628899
13. FT Kolligs G Hu CV Dang ER Fearon 1999 Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression Mol Cell Biol 19 5696 5706 1:CAS:528: DyaK1MXkvVKjtrw%3D 10409758
14. P Polakis 2000 Wnt signaling and cancer Genes Dev 14 1837 1851 1:CAS:528:DC%2BD3cXls1yqsbc%3D 10921899
15. H Shiina JE Breault WW Basset, et al. 2005 Functional loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer Cancer Res 65 2130 2138 1:CAS:528:DC%2BD2MXisFGguro%3D 10.1158/0008-5472.CAN-04-3398 15781623
16. I Simcha B Geiger S Yehuda-Levenberg D Salomon A Ben-Ze'ev 1996 Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin J Cell Biol 133 199 209 1:CAS:528:DyaK28XitVChtbw%3D 10.1083/jcb.133.1.199 8601608
17. JE Breault H Shiina M Igawa, et al. 2005 Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma Clin Cancer Res 11 557 564 1:CAS:528:DC%2BD2MXislWgtL8%3D 15701841
18. RA Winn RM Bremnes L Bemis, et al. 2002 gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth Oncogene 21 7497 7506 1:CAS:528:DC%2BD38XnvFWjsbw%3D 10.1038/sj.onc.1205963 12386812
19. BG Taal TH Van FA Zoetmulder 2001 Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III Br J Cancer 85 1437 1443 1:CAS:528:DC%2BD38Xkslentg%3D%3D 10.1054/bjoc.2001.2117 11720425
20. IMPACT-investigators 1995 Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators Lancet 345 939 944 10.1016/S0140-6736(95)90696-7
21. CG Moertel TR Fleming JS Macdonald, et al. 1995 Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer J Clin Oncol 13 2936 2943 1:CAS:528:DyaK28XmslOmsA%3D%3D 8523058
22. HC Moore DG Haller 1999 Adjuvant therapy of colon cancer Semin Oncol 26 545 555 1:CAS:528:DyaK1MXntFOktbw%3D 10528903
23. G Quasar Collaborative R Gray J Barnwell, et al. 2007 Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 2020 2029 10.1016/S0140-6736(07)61866-2
24. W Schippinger H Samonigg R Schaberl-Moser, et al. 2007 A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer Br J Cancer 97 1021 1027 1:CAS:528:DC%2BD2sXhtFKktb7N 10.1038/sj.bjc.6604011 17895886
25. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 1420 1425 10.1093/jnci/djh275 15467030
26. S Hakimelahi HR Parker AJ Gilchrist, et al. 2000 Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2 J Biol Chem 275 10905 10911 1:CAS:528:DC%2BD3cXislShsLg%3D 10.1074/jbc.275.15.10905 10753888
27. H Pan F Gao P Papageorgis HM Abdolmaleky DV Faller S Thiagalingam 2007 Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression Cancer Biol Ther 6 1638 1643 1:CAS:528:DC%2BD1cXjslWlsLY%3D 10.4161/cbt.6.10.4904 18245958
28. BM Ghadimi J Behrens I Hoffmann W Haensch W Birchmeier PM Schlag 1999 Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling Eur J Cancer 35 60 65 1:CAS:528:DyaK1MXhslGgu7k%3D 10.1016/S0959-8049(98)00344-X 10211089
29. T Gastaldi P Bonvini F Sartori A Marrone A Iolascon A Rosolen 2006 Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation Carcinogenesis 27 1758 1767 1:CAS:528:DC%2BD28Xotl2ms7s%3D 10.1093/carcin/bgl008 16537559
30. J Bondi G Bukholm JM Nesland IR Bukholm 2004 Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas APMIS 112 49 56 1:CAS:528: DC%2BD2cXislyisL4%3D 10.1111/j.1600-0463.2004.apm1120109.x 14961975